Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DELAT PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership1,298,173 shares
Latest Disclosed Value $ 4,647,459
UBS Group AG reports 757.26% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 1,298,173 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $3,654,357 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 151,432 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 757.26% during the quarter. The current value of the position is $3,167,542 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,298,173 1,146,741 757.26 4,647 775.14 0.0007
2026-01-29 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 151,432 -381,560 -71.59 532 -69.43 0.0001
2025-11-13 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 532,992 -303,516 -36.28 1,738 -15.23 0.0003
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 836,508 188,678 29.12 2,049 -52.58 0.0004
2025-05-13 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 647,830 77,867 13.66 4,321 -39.68 0.0008
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 569,963 231,829 68.56 7,164 14.72 0.0013
2024-11-14 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 338,134 -67,648 -16.67 6,245 -28.51 0.0014
2024-08-14 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 405,782 -103,172 -20.27 8,736 -36.28 0.0022
2024-05-13 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 508,954 466,150 1,089.03 13,711 969.50 0.0034
2024-02-09 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 42,804 -215,425 -83.42 1,283 -75.77 0.0004
2023-11-09 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 258,229 230,812 841.86 5,291 872.61 0.0018
2023-08-11 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 27,417 -88,737 -76.40 545 -72.65 0.0002
2023-05-12 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 116,154 -179,107 -60.66 1,990 -65.58 0.0007
2023-02-08 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 295,261 198,358 204.70 5,778 273.50 0.0022
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 96,903 30,116 45.09 1,547 68.34 0.0007
2022-08-10 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 66,787 -107,410 -61.66 919 -66.74 0.0004
2022-05-16 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 174,197 33,465 23.78 2,763 -10.06 0.0009
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 140,732 44,829 46.74 3,072 7.15 0.0009
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 95,903 83,742 688.61 2,867 431.91 0.0009
2021-08-13 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 12,161 -62,052 -83.61 539 -83.63 0.0002
2021-05-12 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 74,213 28,048 60.76 3,293 30.06 0.0011
2021-02-11 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 46,165 25,991 128.83 2,532 449.24 0.0009
2020-11-12 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 20,174 17,126 561.88 461 620.31 0.0002
2020-07-31 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,048 -27,360 -89.98 64 -84.94 0.0000
2020-05-01 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 30,408 -25,706 -45.81 425 -66.72 0.0002
2020-02-14 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 56,114 3,763 7.19 1,277 109.34 0.0004
2019-11-14 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 52,351 46,779 839.54 610 626.19 0.0002
2019-08-14 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 5,572 5,562 55,620.00 84 0.0000
2019-05-14 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 10 -18,014 -99.94 0 -100.00
2019-02-14 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 18,024 13,009 259.40 267 117.07 0.0001
2018-11-14 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 5,015 1,376 37.81 123 73.24 0.0000
2018-08-14 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 3,639 2,061 130.61 71 144.83 0.0000
2018-05-15 2018-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,578 1,578 29 0.0000
2017-11-14 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -189 -100.00 0 0.0000
2017-11-14 2017-06-30 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 189 -354 -65.19 0 -100.00
2017-08-14 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 189 -354 0
2017-11-14 2017-03-31 13F/A-1 INOTEK PHARMACEUTICALS COM 45780V102 543 -2,240 -80.49 1 -94.12 0.0000
2017-05-12 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 543 -2,240 1
2017-02-14 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 2,783 1,387 99.36 17 30.77 0.0000
2016-11-14 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 1,396 1,396 0.00 13 0.0000
2016-08-12 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -38,623 -100.00 0 -100.00
2016-05-12 2016-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 38,623 38,519 37,037.50 286 28,500.00 0.0002
2016-02-16 2015-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 104 -5,344 -98.09 1 -98.04 0.0000
2015-11-13 2015-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 5,448 -936 -14.66 51 64.52 0.0000
2015-08-14 2015-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 6,384 5,438 574.84 31 520.00 0.0000
2015-05-14 2015-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 946 946 5 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.